• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[伯氏疟原虫青蒿素抗性品系诱导研究]

[Study on inducing an artemisinin-resistant line of Plasmodium berghei].

作者信息

Chen Ying-dan, Lin Bao-ying, Zhang Jia-xun

机构信息

Institute for Parasitic Disease Control and Prevention, Chinese Center for Disease Control and Prenention, Shanghai 200025.

出版信息

Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2002;20(1):37-8.

PMID:12567543
Abstract

OBJECTIVE

To induce a line of Plasmodium berghei with resistance to artemisinin.

METHODS

The major methods included blood transmission from passage to passage and progressive increase of drug pressure.

RESULTS

The resistant lines were developed by different protocols: (A) The initial dosage of artemisinin was 126.2 mg/kg which was increased by 60 mg/kg for the next passage and boosted by 126.2 mg/kg for every other passage. As developed to passage 60 and 76, the resistant index was 18.39:1 and 14.89:1 respectively, then decreased gradually. For passage 108, the dosage was 8,862.5 mg/kg, but the resistant index was only 10.49:1. (B) Using passage 66 from (A) as the source, a dosage of 4,000 mg/kg was given each week, the resistance of the passage 40 increased significantly with an index of 27.5:1. (C) Using passage 19 of (B) as the source, drug was administered at the dose of 2,000 mg/kg each week. The resistant index of passage 15 was 17.41:1.

CONCLUSION

Line of P. berghei with medium level resistance to artemisinin was established.

摘要

目的

诱导出对青蒿素具有抗性的伯氏疟原虫品系。

方法

主要方法包括逐代血液传代和逐步增加药物压力。

结果

通过不同方案培育出抗性品系:(A)青蒿素初始剂量为126.2mg/kg,下一代增加60mg/kg,每隔一代增加126.2mg/kg。培育至第60代和第76代时,抗性指数分别为18.39:1和14.89:1,随后逐渐下降。至第108代时,剂量为8862.5mg/kg,但抗性指数仅为10.49:1。(B)以(A)中的第66代作为起始,每周给予4000mg/kg的剂量,第40代的抗性显著增加,指数为27.5:1。(C)以(B)中的第19代作为起始,每周给予2000mg/kg的药物。第15代的抗性指数为17.41:1。

结论

建立了对青蒿素具有中等水平抗性的伯氏疟原虫品系。

相似文献

1
[Study on inducing an artemisinin-resistant line of Plasmodium berghei].[伯氏疟原虫青蒿素抗性品系诱导研究]
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2002;20(1):37-8.
2
Disordered Metabolic Profiling in Plasma and Tissues of Mice Infected with Artemisinin-Sensitive and -Resistant Plasmodium berghei K173 Determined by H NMR Spectroscopy.基于核磁共振波谱技术的青蒿素敏感和耐药伯氏疟原虫感染小鼠的代谢紊乱分析。
J Proteome Res. 2019 May 3;18(5):1970-1993. doi: 10.1021/acs.jproteome.8b00782. Epub 2019 Apr 11.
3
[The sensitivity of a Plasmodium berghei strain resistant to artemisinin and other antimalarial preparations].
Med Parazitol (Mosk). 1991 Jan-Feb(1):47-50.
4
[Development of artemether-resistant of line of Plasmodium berghei].[伯氏疟原虫蒿甲醚抗性品系的培育]
Zhongguo Yao Li Xue Bao. 1988 Jul;9(4):352-5.
5
Plasmodium berghei K173: selection of resistance to naphthoquine in a mouse model.疟原虫伯氏疟原虫 K173:在小鼠模型中对萘喹啉的抗性选择。
Exp Parasitol. 2011 Feb;127(2):436-9. doi: 10.1016/j.exppara.2010.08.020. Epub 2010 Sep 22.
6
[Development of a line of Plasmodium berghei resistant to sodium artesunate].[对青蒿琥酯耐药的伯氏疟原虫品系的培育]
Zhongguo Yao Li Xue Bao. 1987 Mar;8(2):149-52.
7
In vitro and in vivo anti-malarial activity of novel harmine-analog heat shock protein 90 inhibitors: a possible partner for artemisinin.新型骆驼蓬碱类似物热休克蛋白90抑制剂的体外和体内抗疟活性:一种可能的青蒿素搭档。
Malar J. 2016 Dec 1;15(1):579. doi: 10.1186/s12936-016-1625-7.
8
[Construction of the subtracted cDNA libraries related to artemisinin-resistance of Plasmodium berghei].[伯氏疟原虫青蒿素抗性相关消减cDNA文库的构建]
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2004 Jun;22(3):139-43.
9
Qinghaosu resistance in rodent malaria.啮齿类动物疟疾中的青蒿素抗性
Trans R Soc Trop Med Hyg. 1986;80(3):477-80. doi: 10.1016/0035-9203(86)90351-2.
10
Antimalarial activity and sensitization of chrysosplenetin against artemisinin-resistant genotype Plasmodium berghei K173 potentially via dual-mechanism of maintaining host P-glycoprotein homeostasis mediated by NF-κB p52 or PXR/CAR signaling pathways and regulating heme/haemozoin metabolism.杀虫脒对青蒿素耐药基因型伯氏疟原虫 K173 的抗疟活性及增敏作用可能通过 NF-κB p52 或 PXR/CAR 信号通路介导维持宿主 P-糖蛋白稳态的双重机制和调节血红素/疟原虫色素代谢来实现。
Phytother Res. 2023 Jul;37(7):2939-2956. doi: 10.1002/ptr.7789. Epub 2023 Mar 20.